 Home > Active Ingredient News > Drugs Articles > Development of mRNA therapy for genetic metabolic diseases Moderna reached cooperation

Development of mRNA therapy for genetic metabolic diseases Moderna reached cooperation

 Last Update: 2021-09-10
 Source: Internet
 Author: User

Tags

sudden death syndrome

huperzine side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 7, 2021, Moderna and The Institute for Life Changing Medicines (ILCM) announced a new collaboration to develop a new type of mRNA therapy (mRNA-3351) for patients with type 1 Crigler-Najjar syndrome (CN-1).

According to the terms of the agreement, Moderna will grant ILCM the right to develop mRNA-3351 without upfront fees or any downstream payments.

ILCM is a non-profit research organization co-founded by many leaders and experts in the biomedical industry.

CN-1 is a super rare genetic disease

mRNA-3351 is a drug candidate for the treatment of CN-1

Reference materials:

[1] Moderna and the Institute for Life Changing Medicines Announce a New Collaboration to Develop an mRNA Therapeutic for Ultra-Rare Disease, Crigler-Najjar Syndrome Type 1.

[2] Scoop: Inspired by the late Tachi Yamada, Jim Wilson launches new nonprofit targeting underserved ultra-rare diseases.
Retrieved September 2.
2021.
from https://endpts.
com/scoop-inspired-by-the-late-tachi -yamada-jim-wilson-launches-new-nonprofit-targeting-underserved-ultra-rare-diseases/

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Top Product

$49-62/KG FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

Hot Sale 1-Adamantanamine Hydrochloride /1-Adamantanamine HCl CAS 665-66-7

CAS No.: 665-66-7

Pharmacy Grade

$20-25/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.